IDH1 and central nervous system cancer: Here, based on two specific single-cell sequencing results on the three subgroups of gliomas (glioblastoma, diffuse astrocytoma, and anaplastic astrocytoma) with confirmed mutant IDH1 [21], we used several advanced computational methods to identify potential differentially expressed biomarkers for the distinction of the different glioma subgroups.